CpG Island Hypermethylation in Gastric Carcinoma and Its Premalignant Lesions

키워드

참고문헌 (78)

1. Saxonov S, "A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters", Proc Natl Acad Sci U S A, 103, pp.1412~1417 (2006)
2. Esteller M, "A gene hypermethylation profile of human cancer", Cancer Res, 61, pp.3225~3229 (2001)
3. Baylin SB, "Alterations in DNA methylation: a fundamental aspect of neoplasia", Adv Cancer Res, 72, pp.141~196 (1998)
4. Seog Yun Park, "Methylation Profiles of CpG Island Loci in Major Types of Human Cancers", Journal of Korean Medical Science, 22(2), pp.311~317 (2007), 대한의학회
5. Lee YY, "Alterations of p16INK4A and p15INK4B genes in gastric carcinomas", Cancer, 80, pp.1889~1896 (1997)
6. Yamashita S, "Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2’-deoxycytidine treatment and oligonucleotide microarray", Cancer Sci, 97, pp.64~71 (2006)
7. Kang GH, "CpG island methylation in premalignant stages of gastric carcinoma", Cancer Res, 61, pp.2847~2851 (2001)
8. Kang GH, "Profile of aberrant CpG island methylation along multistep gastric carcinogenesis", Lab Invest, 83, pp.519~526 (2003)
9. Yoo EJ, "Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection", Journal of Pathology, 219(4), pp.410~416 (2009), John Wiley & Sons Inc.
10. Chan AO, "Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer", Gut, 52, pp.502~506 (2003)
11. Waki T, "Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia", Am J Pathol, 161, pp.399~403 (2002)
12. Kang GH, "Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation", Am J Pathol, 163, pp.1551~1556 (2003)
13. Chan AO, "Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation", Gut, 55, pp.463~468 (2006)
14. Leung WK, "Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach", Clin Cancer Res, 12, pp.3216~3221 (2006)
15. Ushijima T, "DNA methylation as a marker for the past and future", J Gastroenterol, 41, pp.401~407 (2006)
16. Hmadcha A, "Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production", J Exp Med, 190, pp.1595~1604 (1999)
17. Qian X, "E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines", Cancer Lett, 263, pp.107~113 (2008)
18. Niwa T, "Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells", Cancer Res, 70, pp.1430~1440 (2010)
19. 허근, "Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation", CARCINOGENESIS, 32(1), pp.35~41, OXFORD UNIV PRESS
20. Illingworth R, "A novel CpG island set identifies tissue-specific methylation at developmental gene loci", PLoS Biol, 6, pp.22~ (2008)
21. Shen L, "Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters", PLoS Genet, 3, pp.2023~2036 (2007)
22. Issa JP, "Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon", Nat Genet, 7, pp.536~540 (1994)
23. Ahuja N, "Aging and DNA methylation in colorectal mucosa and cancer", Cancer Res, 58, pp.5489~5494 (1998)
24. Drumm B, "Intrafamilial clustering of Helicobacter pylori infection", N Engl J Med, 322, pp.359~363 (1990)
25. Chan AO, "Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related?", Am J Pathol, 163, pp.370~371 (2003)
26. Maekita T, "High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk", Clin Cancer Res, 12(3 Pt 1), pp.989~995 (2006)
27. 박석연, "Aberrant CpG Island Hypermethylation in Pediatric Gastric Mucosa in Association With Helicobacter pylori Infection", ARCHIVES OF PATHOLOGY LABORATORY MEDICINE, 135(6), pp.759~765, COLLEGE AMER PATHOLOGISTS
28. Barzily-Rokni M, "Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A)", Nucleic Acids Res, 39, pp.1326~1335 (2011)
29. Leung WK, "Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues", Cancer, 91, pp.2294~2301 (2001)
30. Honmyo U, "Clinicopathological analysis of synchronous multiple gastric carcinoma", Eur J Surg Oncol, 15, pp.316~321 (1989)
31. Marrano D, "Synchronous and metachronous cancer of the stomach", Eur J Surg Oncol, 13, pp.493~498 (1987)
32. Nakajima T, "Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers", Cancer Epidemiol Biomarkers Prev, 15, pp.2317~2321 (2006)
33. Kaise M, "CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk", Helicobacter, 13, pp.35~41 (2008)
34. Stemmermann GN, "Intestinal metaplasia of the stomach: a status report", Cancer, 74, pp.556~564 (1994)
35. Shimoyama T, "Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori", Virchows Arch, 436, pp.585~587 (2000)
36. Buffart TE, "MAL promoter hypermethylation as a novel prognostic marker in gastric cancer", Br J Cancer, 99, pp.1802~1807 (2008)
37. de Maat MF, "Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer", J Clin Oncol, 25, pp.4887~4894 (2007)
38. Kato K, "Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer", Int J Cancer, 122, pp.603~608 (2008)
39. Jin SH, "IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells", Int J Cancer, 122, pp.1040~1046 (2008)
40. Otsubo T, "SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis", Br J Cancer, 98, pp.824~831 (2008)
41. Wanajo A, "Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer", Gastroenterology, 135, pp.580~590 (2008)
42. 라선영, "Promoter Methylation of the Wnt", beta-Catenin Signaling Antagonist Dkk-3 Is Associated With Poor Survival in Gastric Cancer, 200901, pp.115(1), 49~60
43. 김진, "Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma", European Journal of Cancer, 45(7), pp.1282~1293, Pergamon Press Ltd.
44. Chen X, "Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation", Biochem Biophys Res Commun, 391, pp.1070~1074 (2010)
45. Herman JG, "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands", Proc Natl Acad Sci U S A, 93, pp.9821~9826 (1996)
46. Toyota M, "CpG island methylator phenotype in colorectal cancer", Proc Natl Acad Sci U S A, 96, pp.8681~8686 (1999)
47. 김명진, "CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer", NATURE GENETICS, 38(7), pp.787~793, NATURE PUBLISHING GROUP
48. Ogino S, "Molecular classification and correlates in colorectal cancer", J Mol Diagn, 10, pp.13~27 (2008)
49. 김정호, "Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers", VIRCHOWS ARCHIV, 455, pp.485~494, Springer
50. Toyota M, "Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype", Cancer Res, 59, pp.5438~5442 (1999)
51. Enomoto S, "Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae", Cancer Sci, 98, pp.1853~1861 (2007)
52. Chang MS, "CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus", Clin Cancer Res, 12, pp.2995~3002 (2006)
53. Kang GH, "Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma", Am J Pathol, 160, pp.787~794 (2002)
54. Kusano M, "Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus", Cancer, 106, pp.1467~1479 (2006)
55. Oue N, "DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype", Cancer Sci, 94, pp.901~905 (2003)
56. An C, "Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma", Clin Cancer Res, 11(2 Pt 1), pp.656~663 (2005)
57. Park SY, "CpG island hypermethylator phenotype in gastric carcinoma and its clinicopathological features", Virchows Arch, 457, pp.415~422 (2010)
58. Imai S, "Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein", Proc Natl Acad Sci U S A, 91, pp.9131~9135 (1994)
59. Fukayama M, "Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach", Lab Invest, 71, pp.73~81 (1994)
60. Fukayama M, "Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma", Cancer Sci, 99, pp.1726~1733 (2008)
61. Kang GH, "DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis", Lab Invest, 88, pp.161~170 (2008)
62. Etoh T, "Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers", Am J Pathol, 164, pp.689~699 (2004)
63. Hino R, "Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma", Cancer Res, 69, pp.2766~2774 (2009)
64. 김현기, "High microsatellite instability predicts good prognosis in intestinal-type gastric cancers", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26(3), pp.585~592 (2011), BLACKWELL PUBLISHING ASIA PTY LTD
65. Gylling A, "Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study", Gut, 56, pp.926~933 (2007)
66. Kang GH, "Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis", Lab Invest, 83, pp.635~641 (2003)
67. Park SJ, "Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas", ONCOGENE, 23(26), pp.4646~4654 (2004), NATURE PUBLISHING GROUP
68. Ling ZQ, "Microsatellite instability with promoter methylation and silencing of hMLH1 can regionally occur during progression of gastric carcinoma", Cancer Lett, 297, pp.244~251 (2010)
69. Saito Y, "Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells", Cancer Cell, 9, pp.435~443 (2006)
70. Sato F, "MicroRNAs and epigenetics", FEBS J, 278, pp.1598~1609 (2011)
71. Saito Y, "Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells", Oncogene, 28, pp.2738~2744 (2009)
72. Tsukamoto Y, "MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta", Cancer Res, 70, pp.2339~2349 (2010)
73. Wada R, "miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer", Int J Cancer, 127, pp.1106~1114 (2010)
74. Tsai KW, "Epigenetic regulation of miR-196b expression in gastric cancer", Genes Chromosomes Cancer, 49, pp.969~980 (2010)
75. Chen Q, "miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42", Dig Dis Sci, 56, pp.2009~2016 (2011)
76. Shen R, "Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer", Biochem Biophys Res Commun, 394, pp.1047~1052 (2010)
77. Ando T, "DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect", Int J Cancer, 124, pp.2367~2374 (2009)
78. Suzuki H, "Methylation-associated silencing of microRNA-34b", c in gastric cancer and its involvement in an epigenetic field defect, 2010, pp.31, 2066~2073

관련 논문AI추천